estramustine

Related by string. * * *

Related by context. All words. (Click for frequent words.) 78 cisplatin gemcitabine 76 FUSILEV enhances 75 pegylated liposomal doxorubicin 74 anthracycline taxane 74 Pemetrexed 74 relapsed MM 74 doxorubicin cyclophosphamide 74 Tarceva TM 74 Folfox 74 gemcitabine cisplatin 74 flutamide 74 Platinol ® cisplatin 73 5 FU leucovorin 73 alfa 2a 73 zoledronate 73 adriamycin 73 evaluating tivozanib 73 Doxil ® 73 recurrent glioblastoma multiforme 73 demonstrated antitumor activity 73 alkylating agent 73 gemcitabine carboplatin 72 cyclophosphamide methotrexate 72 ara C 72 CIMZIA TM 72 FOLFIRI 72 nab paclitaxel 72 sorafenib Nexavar 72 lenalidomide Revlimid R 72 ribavirin RBV 72 mitoxantrone plus 72 Irinotecan 72 4mg/kg 72 Flu Cy 72 adalimumab Humira 72 dexamethasone Decadron 72 5 Fluorouracil 72 #mg/m# [001] 72 8mg/kg 72 FOLFOX6 72 paclitaxel Taxol 72 mitoxantrone chemotherapy 72 pomalidomide 72 5 fluorouracil leucovorin 72 fluorouracil 72 Fulvestrant 71 taxane refractory 71 oblimersen 71 goserelin 71 Peginterferon alfa 2b 71 MGd 71 heavily pretreated patients 71 docetaxel chemotherapy 71 galiximab 71 docetaxel Taxotere ® 71 plus prednisone 71 Taxotere ® 71 Hormone Refractory Prostate Cancer 71 novel VDA molecule 71 interferon alfa 71 paclitaxel Taxol ® 71 melphalan prednisone 71 ELACYT 71 VNP#M 71 metastatic GIST 71 CYT# potent vascular disrupting 71 metastatic malignant 71 pharmacologically active isomer 71 dasatinib Sprycel 71 #mg/m# [002] 71 ritonavir boosted 71 chemotherapy cisplatin 71 5FU 71 Omacetaxine 71 bortezomib Velcade 71 paclitaxel carboplatin 71 plus prednisone prednisolone 71 carboplatin paclitaxel 71 PEGylated anti 71 MAGE A3 ASCI 71 lenalidomide dexamethasone 71 gemcitabine Gemzar 71 dasatinib Sprycel ® 71 abacavir lamivudine 71 Capecitabine 71 Xelox 71 ® lenalidomide 71 gefitinib Iressa 71 daunorubicin 71 TO AVOID PREGNANCY WHILE 71 concurrent chemoradiation 71 dacarbazine 71 thalidomide Thalomid 70 Fluorouracil 70 CHOP chemotherapy 70 antiandrogen 70 irinotecan doxorubicin oxaliplatin paclitaxel 70 Dasatinib 70 administered subcutaneously 70 gemcitabine chemotherapy 70 cisplatin chemotherapy 70 receptor tyrosine kinase inhibitor 70 Neoadjuvant 70 weekly subcutaneous injections 70 idarubicin 70 anti leukemic 70 mTOR inhibitors 70 Vidaza azacitidine 70 cyclophosphamide chemotherapy 70 Bezielle 70 5-FU/LV 70 Fludara 70 erlotinib Tarceva ® 70 metastatic castration resistant 70 dacarbazine DTIC 70 PEGylated Fab fragment 70 Degarelix 70 TAXOTERE R 70 vinorelbine 70 Xeloda ® 70 Peg IFN 70 sitaxsentan 70 liposomal doxorubicin 70 FOLFOX4 70 Pegylated Interferon 70 gemcitabine Gemzar ® 70 interferon alfa 2b 70 oral rivaroxaban 70 IMiDs ® 70 clodronate 70 vinca alkaloid 70 mapatumumab 70 Camptosar ® 70 SPRYCEL ® 70 PSMA ADC 70 achieved ACR# 70 folinic acid 70 paclitaxel cisplatin 70 cis retinoic acid 70 cyclophosphamide doxorubicin vincristine 70 Xanafide 70 bleomycin 70 receiving INTRON 70 epirubicin 70 plus gemcitabine 69 viral kinetics 69 docetaxel Taxotere 69 APTIVUS r 69 Aflibercept 69 humanised monoclonal antibody 69 Fludarabine 69 leukemia AML 69 epirubicin cyclophosphamide 69 Temsirolimus 69 Pegylated interferon 69 heavily pretreated 69 pegylated interferon alfa 2a 69 taxane chemotherapy 69 #mg BID [003] 69 Cloretazine 69 hormone refractory metastatic prostate 69 anthracyclines taxanes 69 imatinib therapy 69 receptor blocker 69 prednisone prednisolone 69 sunitinib Sutent 69 epirubicin cisplatin 69 ixabepilone 69 YONDELIS 69 Orally administered 69 plus dexamethasone 69 metastatic hormone refractory 69 bevacizumab Avastin R 69 EGFR expressing mCRC 69 pharmacokinetic interactions 69 adjuvant cisplatin 69 papillary renal cell carcinoma 69 octreotide LAR 69 ibandronate 69 hA# 69 selective modulator 69 DOXIL 69 paricalcitol 69 oral prodrug 69 CR nPR 69 generation purine nucleoside 69 beta 1a 69 IMiDs ® compound 69 paclitaxel Taxol R 69 hydroxymethyl coenzyme 69 sunitinib Sutent ® 69 sorafenib Nexavar ® 69 mycophenolate mofetil 69 PROSTVAC VF 69 Seliciclib 69 Kinoid 69 sorafenib tablets 69 sulindac 69 trastuzumab Herceptin R 69 Refractory Hodgkin Lymphoma 69 somatostatin analog 69 Pegylated Liposomal Doxorubicin 69 chlorambucil 69 comparator arm 69 neoadjuvant 69 low dose cytarabine 69 liposomal formulation 69 fluoropyrimidine 69 doxorubicin docetaxel 69 nadolol 69 mertansine 69 progression TTP 69 CA4P 69 locoregional recurrence 69 relapsed ovarian cancer 69 standard chemotherapy regimen 69 sunitinib malate 69 chemotherapy FOLFOX 69 cilengitide 69 forodesine 69 cetuximab Erbitux ® 69 Taxol ® 69 Amrubicin 69 radiochemotherapy 69 Platinol ® 69 temozolomide 69 potentially hepatotoxic 68 Hycamtin ® 68 Pegasys plus Copegus 68 decitabine 68 CIMZIA TM certolizumab pegol 68 Panzem R NCD 68 neoadjuvant treatment 68 pamidronate 68 R lenalidomide 68 ZACTIMA 68 TTF Therapy 68 pegylated interferon peg IFN 68 Copegus ribavirin 68 Panzem NCD 68 mg qd 68 complete cytogenetic response 68 recurrent metastatic 68 KRAS mutant tumors 68 Nilotinib 68 Ophena TM 68 azacytidine 68 huN# DM1 68 small molecule tyrosine 68 HER2 positive metastatic breast 68 CLL SLL 68 Peginterferon 68 bendamustine 68 Hsp# Inhibitor 68 mg/m2 administered 68 docetaxel prednisone 68 EGFR TKI 68 Bortezomib 68 ZOLINZA 68 mg RDEA# 68 HMG CoA reductase inhibitor 68 oral chemotherapeutic agent 68 Elotuzumab 68 cetuximab Erbitux R 68 Bevacizumab 68 refractory chronic lymphocytic 68 riociguat 68 ACTEMRA TM 68 Mg Usa 68 fluorouracil leucovorin 68 Gemcitabine 68 paclitaxel poliglumex 68 factor TNF 68 chemoradiotherapy 68 cabazitaxel 68 chemoradiation therapy 68 metastatic colorectal carcinoma 68 mitoxantrone 68 orally administered inhibitor 68 Bosutinib 68 cytarabine daunorubicin 68 androgen independent 68 GW# [003] 68 #mg #mg #mg [003] 68 PEG IFN 68 topoisomerase II inhibitor 68 HGS ETR2 68 Cloretazine ® 68 biologic DMARD 68 mRCC 68 AAG geldanamycin analog 68 assessing T DM1 68 Alkeran 68 achieved CCyR 68 Cytoxan 68 monoclonal antibody conjugated 68 EGFR tyrosine kinase inhibitor 68 irinotecan chemotherapy 68 TNF Tumor Necrosis Factor 68 Known hypersensitivity 68 Diffuse Large B 68 trastuzumab Herceptin ® 68 antiretroviral naïve 68 alvespimycin 68 Cimzia TM 68 mcg BID 68 pertuzumab 68 cediranib 68 maximally tolerated dose 68 Vandetanib 68 amprenavir 68 pegylated interferon alpha 68 bevacizumab Avastin ® 68 anastrazole 68 q8h 68 neratinib 68 biochemical relapse 68 piperacillin tazobactam 68 CIMZIA ™ 68 Triapine R 68 erlotinib Tarceva 68 Enzastaurin 68 Telintra 68 vitamin B# folic acid 68 Gefitinib 68 Pharmacokinetics PK 68 FEMALES SHOULD BE ADVISED 68 mg/m2 IV 68 etoposide 68 dalteparin 68 oral Hycamtin 68 interferon gamma 1b 68 sargramostim 68 alefacept 68 systemic ALCL 68 refractory NSCLC 68 AZT zidovudine Retrovir 67 Pertuzumab 67 postoperative chemotherapy 67 oxaliplatin Eloxatin 67 cyclophosphamide Cytoxan 67 PREZISTA r 67 pegylated interferon alfa 67 biliary tract cancer 67 Cutaneous T 67 taxane resistant 67 temsirolimus 67 docetaxel Taxotere R 67 OMP #R# 67 Tyrima 67 raloxifene Evista 67 fosbretabulin 67 mg m² 67 ELOXATIN 67 Pegasys ® 67 plasma kallikrein inhibitor 67 bortezomib Velcade R 67 eribulin mesylate 67 Toremifene 67 stage IIIb IV 67 chemotherapy docetaxel 67 Taxotere chemotherapy 67 imatinib Gleevec ® 67 synthase TS 67 Intravitreal 67 receptor inhibitor 67 CTAP# Capsules 67 milatuzumab 67 LHRH receptor positive 67 BCG refractory 67 Vidaza ® 67 xenograft models 67 saline placebo 67 #mg/day [002] 67 oral levofloxacin 67 intermittent dosing 67 metaglidasen 67 trabectedin 67 FOLPI 67 nicardipine 67 pegylated liposomal doxorubicin PLD 67 capecitabine Xeloda 67 evaluating picoplatin 67 antiangiogenic agent 67 epoetin alpha 67 oral deforolimus 67 novel emulsion formulation 67 Darinaparsin 67 Gemzar ® 67 APTIVUS 67 TAXOTERE ® 67 metastatic colorectal 67 injected subcutaneously 67 infusional 5-FU/LV 67 Femara letrozole 67 lymphoid malignancies 67 Paraplatin ® 67 remission induction 67 irbesartan 67 recurrent NSCLC 67 intravenously administered 67 FOLFOX6 chemotherapy regimen 67 cardiotoxic 67 selectively inhibited 67 virus HCV protease inhibitor 67 BEACOPP 67 Gleevec resistant 67 ceftazidime 67 imatinib Gleevec 67 Aptivus ® 67 receiving prophylactic anticoagulation 67 Combination therapy 67 thetreatment 67 antitumor effect 67 androgen suppression 67 motesanib 67 Camptosar ® irinotecan 67 PegIFN RBV 67 #mg BID [001] 67 Dacogen decitabine 67 peginterferon alpha 2a 67 Epirubicin 67 Peginterferon Alfa 2a 67 Golimumab 67 Etoposide 67 non resectable metastatic 67 receiving highly emetogenic 67 antiangiogenic therapy 67 nucleoside analog 67 Albuferon TM 67 Apoptone 67 luteinizing hormone releasing 67 infliximab monotherapy 67 ribavirin therapy 67 alpha 2a 67 chemotherapeutic drug 67 Mitoxantrone 67 intratumoral injection 67 interferon alfa 2a 67 novel tubulin binding 67 itraconazole Sporanox 67 salmeterol fluticasone 67 pain palliation 67 Erlotinib 67 palifermin 67 peginterferon alfa 67 relapsed refractory multiple myeloma 67 3TC lamivudine Epivir 67 mg TID 67 imexon 67 AEG# 67 desvenlafaxine succinate 67 IFN beta 67 CCyR 67 Lenalidomide 67 IAP inhibitor 67 metastatic CRC 67 methotrexate monotherapy 67 Topotecan 67 neurologic progression 67 metastatic neuroendocrine tumors 67 dexpramipexole 67 R# #mg BID 67 Abiraterone acetate 67 Nebulized 67 beclomethasone dipropionate 67 unresectable stage 67 HMG CoA reductase inhibitors 67 potent antiproliferative 67 K ras mutations 67 mGluR5 NAM 67 adjuvant tamoxifen 67 patients receiving myelosuppressive 67 Pazopanib 67 metastatic renal cell carcinoma 67 budesonide foam 67 insulin glulisine 67 tegafur 67 ALGRX 67 relapsed CLL 67 oral clodronate 67 plus dacarbazine 67 omega interferon 67 Parathyroid Hormone 67 darunavir r 67 severe hypersensitivity reactions 67 anti angiogenic agent 67 fallopian tube cancers 67 daily subcutaneous injections 67 Gliadel Wafer 67 IMiDs R 67 urocortin 2 67 INSPIRE Trial Phase III 67 subcutaneous enoxaparin 66 VELCADE melphalan 66 paclitaxel chemotherapy 66 IFN alfa 66 neoadjuvant chemotherapy 66 Paraplatin ® carboplatin 66 unresectable tumors 66 recurrent glioblastoma 66 vinorelbine tartrate 66 Aplidin 66 BRIM2 66 tumor xenograft models 66 tenofovir emtricitabine 66 Decitabine 66 HCV replicon 66 XELOX 66 radiotherapy RT 66 neoadjuvant therapy 66 cyclophosphamide doxorubicin 66 fulvestrant 66 EGFR expressing 66 adjuvant GIST 66 interferon ribavirin 66 FASLODEX 66 CYP#A# substrate 66 uric acid lowering 66 Ziprasidone 66 de novo kidney transplant 66 cisplatin resistant 66 idraparinux 66 PNP inhibitor 66 mutated KRAS 66 abiraterone acetate 66 fumarate 66 subcutaneously administered 66 acyclovir Lauriad R 66 HCV RESPOND 2 66 boosted protease inhibitor 66 5 fluorouracil 66 pegylated alpha interferon 66 Combination REOLYSIN R 66 mg QD 66 Velcade bortezomib 66 OMP #M# 66 relapsed myeloma 66 Ceplene/IL-2 66 Taxol paclitaxel 66 CDK inhibitor 66 preoperative chemotherapy 66 mcg QD 66 q#h 66 Interferon Beta 66 R Saizen R 66 ACAPODENE 66 weekly intravenous infusions 66 reduce serum phosphate 66 pathophysiological effects 66 LT NS# 66 LHRH agonists 66 PEGylated interferon 66 prostate cancer HRPC 66 fluvastatin 66 CYT# QbG# 66 plus COPEGUS 66 refractory metastatic 66 thalidomide dexamethasone 66 DFMO 66 tenofovir Viread 66 stage IIIB 66 lenalidomide Revlimid 66 FOR FURTHER INFORMATION ABOUT 66 prednisone prednisolone plus 66 Voreloxin 66 androgen ablation 66 busulfan 66 AKT inhibitor 66 trastuzumab DM1 66 vorinostat 66 cisplatin vinorelbine 66 PEG SN# 66 Zorbtive TM 66 platinum refractory 66 bicalutamide 66 elevated transaminases 66 #.#mg/dL 66 #.#mg/kg [002] 66 fallopian tube carcinoma 66 recurrent malignant glioma 66 nitazoxanide 66 Immunomodulatory 66 Torisel 66 docetaxel 66 tumors GIST 66 cinacalcet 66 topotecan 66 Allovectin 7 ® 66 caspofungin 66 peg IFN 66 Phase 2b Clinical Trial 66 ß blockers 66 telaprevir dosed 66 corticosteroid dexamethasone 66 3mg/kg 66 gemtuzumab ozogamicin 66 response CCyR 66 subcutaneous SC 66 CYP#A# CYP#D# 66 Navelbine ® 66 amrubicin 66 microtubule inhibitor 66 cytoreduction 66 cisplatin carboplatin 66 dose dexamethasone 66 immunostimulatory 66 vinca alkaloids 66 unfractionated heparin UFH 66 Mg Uk 66 evaluating Xcytrin 66 Cyclophosphamide 66 #mg QD [002] 66 phase Ib 66 cyclophosphamide AC 66 pyrazinamide 66 FOLFOX chemotherapy 66 alfa 2b 66 aspirin clopidogrel 66 KRAS mutations occur 66 Xeloda capecitabine 66 R sorafenib tablets 66 MCyR 66 prucalopride 66 huC# DM4 66 steroid dexamethasone 66 Aurora Kinase 66 TLK# 66 prostate cancer CRPC 66 antibody MAb 66 Gemzar gemcitabine 66 β blockers 66 leukemia CLL 66 KAPIDEX 66 plus 5-FU/LV 66 EZN 66 fibrinolytic 66 anthracycline containing 66 Rituxan rituximab 66 alpha folate receptor 66 Quinamed 66 Antiangiogenic 66 non splenectomized 66 Teriparatide 66 abacavir Ziagen 66 budesonide pMDI 66 mitomycin 66 Natalizumab 66 Afatinib 66 kilogram mg kg 66 dose cohort 66 isoproterenol 66 Prolongs Survival 66 plus methotrexate 66 cancer mCRC 66 Nexavar sorafenib 66 metastatic gastric 66 Platinol 66 leuprorelin 66 selective antagonist 66 antiretroviral naive 66 tolterodine ER 66 tinidazole 66 baminercept 66 Adjuvant Treatment 66 pan histone deacetylase 66 protease inhibitor PI 66 lanreotide 66 lispro 66 hepatic metastases 66 Randomized Phase 66 erythropoietic 66 immunomodulating 66 Navelbine 66 Sanofi Aventis Taxotere 66 GnRH agonist 66 gastrointestinal stromal tumors GIST 66 Monotherapy 66 dosing cohort 66 2 methoxyestradiol 66 tipranavir r 66 antithymocyte globulin 66 vapreotide acetate 66 oral picoplatin 66 azacitidine 66 Taxotere docetaxel 66 ritonavir boosted atazanavir 66 non nucleoside inhibitor 66 Relapsed Refractory Multiple Myeloma 66 metastatic castrate resistant 66 AVASTIN 66 CBLC# 65 Febrile neutropenia 65 Solid Tumors criteria 65 Interferon alpha 65 LY# [003] 65 immunomodulatory therapy 65 selective phosphodiesterase 65 Azacitidine 65 Relapsed Refractory 65 Tumor Necrosis Factor 65 pan HDAC inhibitor 65 verteporfin 65 potent triglyceride lowering 65 LEXIVA r 65 Leucovorin 65 Adjuvant chemotherapy 65 relapsed ALL 65 cetuximab Erbitux 65 mycophenolate mofetil MMF 65 TACE 65 Proellex TM 65 Meets Primary Endpoint 65 metastatic pancreatic 65 Cremophor 65 Free Survival PFS 65 leukotriene receptor antagonist 65 TELINTRA 65 Vincristine 65 SCIg 65 taxane chemotherapy administered 65 Capesaris 65 dasatinib 65 antimetabolite 65 ALB # 65 carboplatin 65 Pegylated 65 antifibrinolytic 65 EndoTAGTM 1 65 lanthanum carbonate 65 FOLFOX 65 Neulasta ® 65 subcutaneous doses 65 monoclonal antibody IgG1 Mab 65 Phase 2b Study 65 bevacizumab Avastin 65 ancrod 65 Trabectedin 65 surgical debulking 65 glycoprotein IIb IIIa inhibitor 65 Panzem R 65 letrozole Femara 65 CR CRu 65 FOLFIRI alone 65 carmustine 65 PD LID 65 TEMODAL 65 Trastuzumab 65 splenectomized patients 65 administered concomitantly 65 mg/m2 dose 65 nucleotide analog 65 atazanavir ritonavir 65 Vinorelbine 65 motesanib diphosphate 65 metastatic malignant melanoma 65 zonisamide SR 65 mycophenolic acid 65 posaconazole 65 FIRMAGON 65 D aspartate NMDA receptor 65 docetaxel Injection Concentrate 65 Roche Xeloda 65 vandetanib 65 Anthracycline 65 NMIBC 65 trandolapril 65 Oral Fingolimod 65 Antitumor Activity 65 advanced pancreatic neuroendocrine 65 EGFr expressing metastatic colorectal 65 Bicalutamide 65 Toxicities 65 FluCAM 65 lumiliximab 65 Helicobacter pylori eradication 65 irinotecan containing 65 multikinase inhibitor 65 castration resistant hormone refractory 65 Abrupt discontinuation 65 #mg dose [002] 65 mg/m2/day 65 DLTs 65 CK # administered 65 receiving immunosuppressive therapy 65 TDF FTC 65 non resectable 65 microtubule targeting 65 FOLFOX4 alone 65 Ozarelix 65 COPEGUS 65 Sphingosine 1 65 chemopreventive agent 65 immune modulatory 65 lapatinib Tykerb 65 PRT# 65 Bendamustine 65 refractory AML 65 essential thrombocythemia ET 65 leucovorin 65 mg kg dose 65 intravenous bisphosphonates 65 intradermal injections 65 Myelodysplastic Syndrome MDS 65 Sapacitabine 65 Naive Patients 65 amifostine 65 Gastrointestinal Stromal Tumors 65 liposome encapsulated 65 thrombocytopenic 65 taxotere 65 ertapenem 65 MYLOTARG 65 severe neutropenia 65 azilsartan medoxomil 65 canakinumab 65 vidofludimus 65 intravenous dosing 65 MDS AML 65 Subgroup analysis 65 elotuzumab 65 vWF 65 Vicinium TM 65 μg dose 65 thiazide diuretic 65 dual endothelin receptor antagonist 65 tipranavir 65 immune modulating 65 ARB telmisartan 65 metastatic androgen independent 65 Pegasys peginterferon alfa 2a 65 HRPC 65 GHRH 65 hematologic toxicity 65 CAELYX 65 plus DOXIL 65 prospectively defined 65 antiresorptive 65 INCB# [001] 65 bolus injection 65 coadministration 65 nonmetastatic 65 bronchodilatory 65 5 FU capecitabine 65 serum phosphate 65 Granulocyte Colony Stimulating Factor 65 intravesical infusion therapy 65 nilotinib Tasigna ® 65 cell lymphoma CTCL 65 nilotinib Tasigna 65 interleukin IL -# 65 alkylating agents 65 subcutaneous dose 65 ganciclovir 65 #mg/#mg 65 myelodysplastic myeloproliferative diseases 65 amikacin 65 colorectal adenoma 65 mTOR inhibitor 65 Sprycel dasatinib 65 cytostatic 65 fludarabine cyclophosphamide 65 depsipeptide 65 clomipramine 65 genotypic resistance 65 Fondaparinux 65 histone deacetylase inhibitor 65 intratumoral 65 Recombinant Human 65 IL# PE#QQR 65 mg kg BID 65 deep venous thromboses 65 refractory colorectal cancer 65 clinically meaningful differences 65 mCRC patients 65 metastatic HER2 negative 65 doxorubicin Adriamycin 65 ganetespib 65 resected pancreatic cancer 65 TORISEL 65 HBeAg seroconversion 65 HSP# inhibitor 65 TLR7 agonist 65 neutropenia dehydration dyspnea 65 ARIMIDEX 65 basal bolus regimen 65 haematologic 65 IIIa inhibitor 65 oral diclofenac 65 peg interferon 65 cidofovir 65 pharmacodynamic PD 65 lopinavir r 65 Oxaliplatin 65 LHRH analogues 65 refractory acute myeloid 65 HGS ETR1 65 Elitek 65 RhuDex TM 65 Hepatotoxicity 65 calcineurin inhibitor 65 Tipranavir 65 anthracycline chemotherapy 65 insulin sensitizing 65 PegIFN 65 iniparib BSI 65 rituximab Rituxan 65 treatment naive genotype 65 Bevacizumab Avastin 65 metastatic bladder 65 neuropathy sparing 65 temozolomide TMZ 65 G#DT 65 IFN α 65 CML CP 65 MKC# MT 65 Safinamide 65 GMX# 65 certolizumab 65 Retreatment 65 Faslodex 65 sulfonylurea metformin 65 Phase Ib II 65 squamous histology 65 SUTENT ® 65 pemetrexed 65 endometrial hyperplasia 65 mTOR inhibition 65 interferon α 65 immunoconjugate 65 xanthine oxidase inhibitor 65 ergot derivatives 65 Darusentan 65 EGFR mutation positive 65 primary hypercholesterolemia 65 #mg/kg [002] 65 Jevtana 65 ARIKACE 65 systemically administered 65 olmesartan 65 bortezomib refractory 65 intravenous cyclophosphamide 65 mTOR mammalian target 65 infusional 65 fibrate drugs 65 Paclitaxel Carboplatin 65 QT QTc 65 castrate resistant prostate cancer 65 refractory ovarian cancer 65 trans retinoic acid 65 chimeric monoclonal antibody 65 mg ustekinumab 65 investigational immunotherapy 65 seliciclib 65 KRN# 65 ADP receptor antagonist 65 Zoledronic acid 65 Pralatrexate 65 ribavirin USP 65 Newly Diagnosed Multiple Myeloma 65 relapsed multiple myeloma 65 investigational protease inhibitor 65 Tarceva erlotinib 65 hMG 65 HGS ETR1 mapatumumab 64 mcg kg 64 chemoradiation 64 mediated inhibition 64 debulking surgery 64 intensive lipid lowering 64 recurrent GBM 64 tigecycline 64 sorafenib Nexavar R 64 PREZISTA ritonavir 64 Renal Impairment 64 FOLFIRINOX 64 aripiprazole Abilify 64 oral allopurinol 64 castrate resistant 64 vincristine doxorubicin 64 voriconazole 64 efaproxiral 64 avosentan 64 prescribed proton pump 64 S/GSK# 64 Imprime PGG 64 induced macular edema 64 intra arterial chemotherapy 64 potent CYP#A# inhibitors 64 Patients Receiving 64 kidney urologic 64 ispinesib administered 64 teriflunomide 64 unresectable HCC 64 colorectal liver metastases 64 antiinflammatory 64 ALN HPN 64 advanced unresectable 64 refractory CTCL

Back to home page